C07C 311/42
To an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl
Official title: to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
C07C311/42 (To an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl) appears on 93 US grants and 59 published applications in this corpus.
Search patents in C07C- Granted patents
- 93
- Published applications
- 59
- Assignees
- 58
- Inventors
- 253
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 5 | 0 |
| 2000 | 3 | 0 |
| 2001 | 6 | 0 |
| 2002 | 4 | 4 |
| 2003 | 8 | 8 |
| 2004 | 3 | 5 |
| 2005 | 6 | 5 |
| 2006 | 1 | 3 |
| 2007 | 0 | 5 |
| 2008 | 5 | 3 |
| 2009 | 5 | 3 |
| 2010 | 1 | 2 |
| 2011 | 2 | 1 |
| 2012 | 5 | 2 |
| 2013 | 1 | 2 |
| 2014 | 3 | 2 |
| 2015 | 0 | 3 |
| 2016 | 0 | 0 |
| 2017 | 2 | 1 |
| 2018 | 3 | 3 |
| 2019 | 2 | 1 |
| 2020 | 1 | 2 |
| 2021 | 2 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for targeting Tregs using CCR8 inhibitors17 Feb 2026US 12,552,753 B2Nanjing Immunophage Biomedical Co., Ltd.
- N-aryl oxamic acids7 Dec 2021US 11,192,850 B2Purdue Research Foundation
- Imaging composition and uses thereof21 Sep 2021US 11,123,316 B2The University of Melbourne
- Imaging composition and uses thereof19 May 2020US 10,653,649 B2The University of Melbourne
- Imaging composition and uses thereof3 Sep 2019US 10,398,660 B2The University of Melbourne
- Compounds As NLRP3 Inflammasome Inhibitors And Their Use As Medicaments18 Sep 2025US 2025/0289810 A1Mam-Age S.R.L.
- Methods and Compositions for Targeting Tregs using CCR8 Inhibitors25 May 2023US 2023/0159446 A1Nanjing Immunophage Biomedical Co., Ltd.
- Methods and compositions for targeting Tregs using CCR8 inhibitors9 Feb 2023US 2023/0038589 A1Nanjing Immunophage Biotech Co., Ltd.
- Novel N-aryl Oxamic Acids7 Oct 2021US 2021/0309606 A1Purdue Research Foundation
- Novel imaging composition and uses thereof6 Aug 2020US 2020/0246286 A1The University of Melbourne
Most cited
By later US patents
- Arylsulfonamido-substituted hydroxamic acids110US 5,455,258 ACiba-Geigy Corporation · 1995
- Arylsulfonamido-substituted hydroxamic acids85US 5,552,419 ACiba-Geigy Corporation · 1996
- Arylsufonamido-substituted hydroxamic acids78US 5,506,242 ACiba-Geigy Corporation · 1996
- Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof75US 6,511,990 B1Sloan-Kettering Institute for Cancer Research · 2003
- Inhibitors of histone deacetylase67US 6,897,220 B2MethylGene Inc. · 2005